Annual Total Liabilities
$114.96 M
+$14.63 M+14.58%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual total liabilities is $114.96 million, with the most recent change of +$14.63 million (+14.58%) on December 31, 2023.
- During the last 3 years, VYGR annual total liabilities has risen by +$7.70 million (+7.18%).
- VYGR annual total liabilities is now -54.96% below its all-time high of $255.25 million, reached on December 31, 2019.
Performance
VYGR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$95.73 M
-$5.08 M-5.04%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly total liabilities is $95.73 million, with the most recent change of -$5.08 million (-5.04%) on September 30, 2024.
- Over the past year, VYGR quarterly total liabilities has dropped by -$19.23 million (-16.73%).
- VYGR quarterly total liabilities is now -69.18% below its all-time high of $310.65 million, reached on March 31, 2019.
Performance
VYGR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VYGR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.6% | -16.7% |
| 3 y3 years | +7.2% | -4.6% |
| 5 y5 years | -12.0% | -4.6% |
VYGR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.4% | -35.4% | at low |
| 5 y | 5-year | -55.0% | +16.4% | -62.5% | at low |
| alltime | all time | -55.0% | +2787.0% | -69.2% | +825.1% |
Voyager Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $95.73 M(-5.0%) |
| Jun 2024 | - | $100.81 M(-21.7%) |
| Mar 2024 | - | $128.71 M(+12.0%) |
| Dec 2023 | $114.96 M(+14.6%) | $114.96 M(-2.9%) |
| Sep 2023 | - | $118.43 M(+1.7%) |
| Jun 2023 | - | $116.51 M(-2.4%) |
| Mar 2023 | - | $119.33 M(+18.9%) |
| Dec 2022 | $100.34 M(+1.6%) | $100.34 M(-2.3%) |
| Sep 2022 | - | $102.66 M(-20.1%) |
| Jun 2022 | - | $128.55 M(-13.3%) |
| Mar 2022 | - | $148.25 M(+50.1%) |
| Dec 2021 | $98.80 M(-7.9%) | $98.80 M(+1.5%) |
| Sep 2021 | - | $97.35 M(-0.9%) |
| Jun 2021 | - | $98.19 M(-3.3%) |
| Mar 2021 | - | $101.51 M(-5.4%) |
| Dec 2020 | $107.26 M(-58.0%) | $107.26 M(+3.6%) |
| Sep 2020 | - | $103.52 M(-53.1%) |
| Jun 2020 | - | $220.57 M(-9.2%) |
| Mar 2020 | - | $242.85 M(-4.9%) |
| Dec 2019 | $255.25 M | $255.25 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $268.06 M(-0.8%) |
| Jun 2019 | - | $270.19 M(-13.0%) |
| Mar 2019 | - | $310.65 M(+137.9%) |
| Dec 2018 | $130.58 M(+159.0%) | $130.58 M(-0.7%) |
| Sep 2018 | - | $131.48 M(-0.9%) |
| Jun 2018 | - | $132.69 M(-3.0%) |
| Mar 2018 | - | $136.73 M(+171.2%) |
| Dec 2017 | $50.43 M(-6.0%) | $50.43 M(-9.5%) |
| Sep 2017 | - | $55.71 M(+4.9%) |
| Jun 2017 | - | $53.12 M(+1.4%) |
| Mar 2017 | - | $52.39 M(-2.3%) |
| Dec 2016 | $53.64 M(-11.2%) | $53.64 M(+1.5%) |
| Sep 2016 | - | $52.86 M(-2.3%) |
| Jun 2016 | - | $54.11 M(-4.0%) |
| Mar 2016 | - | $56.38 M(-6.6%) |
| Dec 2015 | $60.38 M(+483.5%) | $60.38 M(-6.7%) |
| Sep 2015 | - | $64.72 M(-6.3%) |
| Jun 2015 | - | $69.05 M(+567.3%) |
| Dec 2014 | $10.35 M(+159.9%) | $10.35 M |
| Dec 2013 | $3.98 M | - |
FAQ
- What is Voyager Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Voyager Therapeutics?
- What is Voyager Therapeutics annual total liabilities year-on-year change?
- What is Voyager Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly total liabilities year-on-year change?
What is Voyager Therapeutics annual total liabilities?
The current annual total liabilities of VYGR is $114.96 M
What is the all time high annual total liabilities for Voyager Therapeutics?
Voyager Therapeutics all-time high annual total liabilities is $255.25 M
What is Voyager Therapeutics annual total liabilities year-on-year change?
Over the past year, VYGR annual total liabilities has changed by +$14.63 M (+14.58%)
What is Voyager Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VYGR is $95.73 M
What is the all time high quarterly total liabilities for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly total liabilities is $310.65 M
What is Voyager Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VYGR quarterly total liabilities has changed by -$19.23 M (-16.73%)